J. A. Hovinga

发表

A common origin of the 4143insA ADAMTS13 mutation

B. Lämmle, T. Wienker, T. Becker, 2006, Thrombosis and Haemostasis.

Hereditary thrombotic thrombocytopenic purpura and the hereditary TTP registry

J. George, B. Lämmle, P. Knöbl, 2013, Hämostaseologie.

Relation between ADAMTS13 activity and ADAMTS13 antigen levels in healthy donors and patients with thrombotic microangiopathies (TMA)

G. Remuzzi, S. Ferrari, J. K. Kremer Hovinga, 2006, Thrombosis and Haemostasis.

Acquired thrombotic thrombocytopenic purpura

M. Schaller, J. Voorberg, M. Schaller, 2013, Hämostaseologie.

Hereditary thrombotic thrombocytopenic purpura and the hereditary TTP registry.

J. George, B. Lämmle, P. Knöbl, 2013, Hamostaseologie.

Late onset and pregnancy-induced congenital thrombotic thrombocytopenic purpura

B. Lämmle, K. Lackner, I. Scharrer, 2014, Hämostaseologie.

Caplacizumab reduces the frequency of major thromboembolic events, exacerbations and death in patients with acquired thrombotic thrombocytopenic purpura

R. Zeldin, P. Knöbl, F. Peyvandi, 2017, Journal of thrombosis and haemostasis : JTH.

Impaired DNase1‐mediated degradation of neutrophil extracellular traps is associated with acute thrombotic microangiopathies

B. Lämmle, T. Renné, H. Mannherz, 2015, Journal of thrombosis and haemostasis : JTH.

The incidence of thrombotic thrombocytopenic purpura‐hemolytic uremic syndrome: all patients, idiopathic patients, and patients with severe ADAMTS‐13 deficiency

S. Vesely, J. George, B. Lämmle, 2005, Journal of thrombosis and haemostasis : JTH.

Multiple B‐cell clones producing antibodies directed to the spacer and disintegrin/thrombospondin type‐1 repeat 1 (TSP1) of ADAMTS13 in a patient with acquired thrombotic thrombocytopenic purpura

J. V. van Mourik, J. Voorberg, J. K. Kremer Hovinga, 2006, Journal of thrombosis and haemostasis : JTH.

Pathophysiology of thrombotic thrombocytopenic purpura and hemolytic uremic syndrome

M. Schaller, M. Skowronska, J. K. Kremer Hovinga, 2018, Journal of thrombosis and haemostasis : JTH.

Recombinant ADAMTS13 normalizes von Willebrand factor‐cleaving activity in plasma of acquired TTP patients by overriding inhibitory antibodies

H. Ehrlich, P. Knöbl, J. K. Kremer Hovinga, 2011, Journal of Thrombosis and Haemostasis.

Second international collaborative study evaluating performance characteristics of methods measuring the von Willebrand factor cleaving protease (ADAMTS‐13)

B. Lämmle, S. Ferrari, P. Mannucci, 2008, Journal of thrombosis and haemostasis : JTH.

Measurement of ADAMTS‐13 activity in plasma by the FRETS‐VWF73 assay: comparison with other assay methods

B. Lämmle, J. K. Kremer Hovinga, M. Mottini, 2006, Journal of thrombosis and haemostasis : JTH.

Establishment of the WHO 1st International Standard ADAMTS13, plasma (12/252): communication from the SSC of the ISTH

A. Heath, J. K. Kremer Hovinga, A. Hubbard, 2015, Journal of thrombosis and haemostasis : JTH.

Plasma DNA is Elevated in Patients with Deep Vein Thrombosis.

B. Lämmle, D. Wagner, T. Wakefield, 2013, Journal of vascular surgery. Venous and lymphatic disorders.